gsk glp 1 agonist Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review GLP-1 Agonists - What is
Description
An overall benefit of the family of GLP-1RAs was in weight management
Trial numbers are averages
Lipopolysaccharide (LPS), a prototypical bacterial endotoxin, has been identified as a key mediator linking microbial dysbiosis to GLP-1 activation
The evidence currently available indicates that GLP-1 RA could add to the arsenal available to address persistent gaps in the care of people living with T2DM with, or at the risk of, developing CKD and to reduce the residual renal risk present in those who have already developed CKD
10.1523/JNEUROSCI.1661-18.2019 J
10.3233/jad-2005-7107 J
